Identification of Parkinson’s disease candidate genes using CAESAR and screening of MAPT and SNCAIP in South African Parkinson’s disease patients
10.1007/s00702-011-0591-z
Crossref journal-article
Springer Science and Business Media LLC
Journal of Neural Transmission (297)
Bibliography

Keyser, R. J., Oppon, E., Carr, J. A., & Bardien, S. (2011). Identification of Parkinson’s disease candidate genes using CAESAR and screening of MAPT and SNCAIP in South African Parkinson’s disease patients. Journal of Neural Transmission, 118(6), 889–897.

Authors 4
  1. Rowena J. Keyser (first)
  2. Ekow Oppon (additional)
  3. Jonathan A. Carr (additional)
  4. Soraya Bardien (additional)
References 47 Referenced 14
  1. Abou-Sleiman PM, Muqit MM, McDonald NQ, Yang YX, Gandhi S, Healy DG, Harvey K, Harvey RJ, Deas E, Bhatia K, Quinn N, Lees A, Latchman DS, Wood NW (2006) A heterozygous effect for PINK1 mutations in Parkinson’s disease? Ann Neurol 60:414–419 (10.1002/ana.20960) / Ann Neurol by PM Abou-Sleiman (2006)
  2. Bardien S, Keyser R, Yako Y, Lombard D, Carr J (2009) Molecular analysis of the parkin gene in South African patients diagnosed with Parkinson’s disease. Parkinsonism Relat Disord 15:116–121 (10.1016/j.parkreldis.2008.04.005) / Parkinsonism Relat Disord by S Bardien (2009)
  3. Bardien S, Marsberg A, Keyser R, Lombard D, Lesage S, Brice A, Carr J (2010) LRRK2 G2019S mutation: frequency and haplotype data in South African Parkinson’s disease patients. J Neural Transm 117:847–853 (10.1007/s00702-010-0423-6) / J Neural Transm by S Bardien (2010)
  4. Birney E, Andrews D, Caccamo M, Chen Y, Clarke L, Coates G, Cox T, Cunningham F, Curwen V, Cutts T, Down T, Durbin R, Fernandez-Suarez XM, Flicek P, Graf S, Hammond M, Herrero J, Howe K, Iyer V, Jekosch K, Kahari A, Kasprzyk A, Keefe D, Kokocinski F, Kulesha E, London D, Longden I, Melsopp C, Meidl P, Overduin B, Parker A, Proctor G, Prlic A, Rae M, Rios D, Redmond S, Schuster M, Sealy I, Searle S, Severin J, Slater G, Smedley D, Smith J, Stabenau A, Stalker J, Trevanion S, Ureta-Vidal A, Vogel J, White S, Woodwark C, Hubbard TJ (2006) Ensembl 2006. Nucleic Acids Res 34:D556–D561 (10.1093/nar/gkj133) / Nucleic Acids Res by E Birney (2006)
  5. Bonifati V (2007) Genetics of Parkinsonism. Parkinsonism Relat Disord 13(Suppl 3):233–241 (10.1016/S1353-8020(08)70008-7) / Parkinsonism Relat Disord by V Bonifati (2007)
  6. Chung KK, Zhang Y, Lim KL, Tanaka Y, Huang H, Gao J, Ross CA, Dawson VL, Dawson TM (2001) Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease. Nat Med 7:1144–1150 (10.1038/nm1001-1144) / Nat Med by KK Chung (2001)
  7. Connell JW, Rodriguez-Martin T, Gibb GM, Kahn NM, Grierson AJ, Hanger DP, Revesz T, Lantos PL, Anderton BH, Gallo JM (2005) Quantitative analysis of tau isoform transcripts in sporadic tauopathies. Brain Res Mol Brain Res 137:104–109 (10.1016/j.molbrainres.2005.02.014) / Brain Res Mol Brain Res by JW Connell (2005)
  8. Edwards TL, Scott WK, Almonte C, Burt A, Powell EH, Beecham GW, Wang L, Zuchner S, Konidari I, Wang G, Singer C, Nahab F, Scott B, Stajich JM, Pericak-Vance M, Haines J, Vance JM, Martin ER (2010) Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann Hum Genet 74:97–109 (10.1111/j.1469-1809.2009.00560.x) / Ann Hum Genet by TL Edwards (2010)
  9. Engelender S, Kaminsky Z, Guo X, Sharp AH, Amaravi RK, Kleiderlein JJ, Margolis RL, Troncoso JC, Lanahan AA, Worley PF, Dawson VL, Dawson TM, Ross CA (1999) Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions. Nat Genet 22:110–114 (10.1038/8820) / Nat Genet by S Engelender (1999)
  10. Engelender S, Wanner T, Kleiderlein JJ, Wakabayashi K, Tsuji S, Takahashi H, Ashworth R, Margolis RL, Ross CA (2000) Organization of the human synphilin-1 gene, a candidate for Parkinson’s disease. Mamm Genome 11:763–766 (10.1007/s003350010123) / Mamm Genome by S Engelender (2000)
  11. Erali M, Voelkerding KV, Wittwer CT (2008) High resolution melting applications for clinical laboratory medicine. Exp Mol Pathol 85:50–58 (10.1016/j.yexmp.2008.03.012) / Exp Mol Pathol by M Erali (2008)
  12. Farrer M, Skipper L, Berg M, Bisceglio G, Hanson M, Hardy J, Adam A, Gwinn-Hardy K, Aasly J (2002) The tau H1 haplotype is associated with Parkinson’s disease in the Norwegian population. Neurosci Lett 322:83–86 (10.1016/S0304-3940(02)00106-4) / Neurosci Lett by M Farrer (2002)
  13. Funayama M, Hasegawa K, Kowa H, Saito M, Tsuji S, Obata F (2002) A new locus for Parkinson’s disease (PARK8) maps to chromosome 12p11.2–q13.1. Ann Neurol 51:296–301 (10.1002/ana.10113) / Ann Neurol by M Funayama (2002)
  14. Fung HC, Scholz S, Matarin M, Simon-Sanchez J, Hernandez D, Britton A, Gibbs JR, Langefeld C, Stiegert ML, Schymick J, Okun MS, Mandel RJ, Fernandez HH, Foote KD, Rodriguez RL, Peckham E, De Vrieze FW, Gwinn-Hardy K, Hardy JA, Singleton A (2006) Genome-wide genotyping in Parkinson’s disease and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol 5:911–916 (10.1016/S1474-4422(06)70578-6) / Lancet Neurol by HC Fung (2006)
  15. Gaulton KJ, Mohlke KL, Vision TJ (2007) A computational system to select candidate genes for complex human traits. Bioinformatics 23:1132–1140 (10.1093/bioinformatics/btm001) / Bioinformatics by KJ Gaulton (2007)
  16. Gibb WR, Lees AJ (1988) A comparison of clinical and pathological features of young- and old-onset Parkinson’s disease. Neurology 38:1402–1406 (10.1212/WNL.38.9.1402) / Neurology by WR Gibb (1988)
  17. Harris MA, Clark J, Ireland A, Lomax J, Ashburner M, Foulger R, Eilbeck K, Lewis S, Marshall B, Mungall C, Richter J, Rubin GM, Blake JA, Bult C, Dolan M, Drabkin H, Eppig JT, Hill DP, Ni L, Ringwald M, Balakrishnan R, Cherry JM, Christie KR, Costanzo MC, Dwight SS, Engel S, Fisk DG, Hirschman JE, Hong EL, Nash RS, Sethuraman A, Theesfeld CL, Botstein D, Dolinski K, Feierbach B, Berardini T, Mundodi S, Rhee SY, Apweiler R, Barrell D, Camon E, Dimmer E, Lee V, Chisholm R, Gaudet P, Kibbe W, Kishore R, Schwarz EM, Sternberg P, Gwinn M, Hannick L, Wortman J, Berriman M, Wood V, de la Cruz N, Tonellato P, Jaiswal P, Seigfried T, White R (2004) The gene ontology (GO) database and informatics resource. Nucleic Acids Res 32:D258–D261 (10.1093/nar/gkh036) / Nucleic Acids Res by MA Harris (2004)
  18. Hirokawa N (1994) Microtubule organization and dynamics dependent on microtubule-associated proteins. Curr Opin Cell Biol 6:74–81 (10.1016/0955-0674(94)90119-8) / Curr Opin Cell Biol by N Hirokawa (1994)
  19. Kelso J, Visagie J, Theiler G, Christoffels A, Bardien S, Smedley D, Otgaar D, Greyling G, Jongeneel CV, McCarthy MI, Hide T, Hide W (2003) eVOC: a controlled vocabulary for unifying gene expression data. Genome Res 13:1222–1230 (10.1101/gr.985203) / Genome Res by J Kelso (2003)
  20. Keyser RJ, Lesage S, Brice A, Carr J, Bardien S (2010a) Assessing the prevalence of PINK1 genetic variants in South African patients diagnosed with early- and late-onset Parkinson’s disease. Biochem Biophys Res Commun 398:125–129 (10.1016/j.bbrc.2010.06.049) / Biochem Biophys Res Commun by RJ Keyser (2010)
  21. Keyser RJ, Lombard D, Veikondis R, Carr J, Bardien S (2010b) Analysis of exon dosage using MLPA in South African Parkinson’s disease patients. Neurogenetics 11:305–312 (10.1007/s10048-009-0229-6) / Neurogenetics by RJ Keyser (2010)
  22. Kim HJ, Jeon BS, Yun JY, Seong MW, Park SS, Lee JY (2010) Screening for MAPT and PGRN mutations in Korean patients with PSP/CBS/FTD. Parkinsonism Relat Disord 16:305–306 (10.1016/j.parkreldis.2010.01.004)
  23. Klein C, Lohmann-Hedrich K (2007) Impact of recent genetic findings in Parkinson’s disease. Curr Opin Neurol 20:453–464 (10.1097/WCO.0b013e3281e6692b) / Curr Opin Neurol by C Klein (2007)
  24. Lee G, Neve RL, Kosik KS (1989) The microtubule binding domain of tau protein. Neuron 2:1615–1624 (10.1016/0896-6273(89)90050-0) / Neuron by G Lee (1989)
  25. Lesage S, Brice A (2009) Parkinson’s disease: from monogenic forms to genetic susceptibility factors. Hum Mol Genet 18:R48–R59 (10.1093/hmg/ddp012) / Hum Mol Genet by S Lesage (2009)
  26. Maglott D, Ostell J, Pruitt KD, Tatusova T (2005) Entrez Gene: gene-centered information at NCBI. Nucleic Acids Res 33:D54–D58 (10.1093/nar/gki031) / Nucleic Acids Res by D Maglott (2005)
  27. Maraganore DM, de Andrade AM, Lesnick TG, Strain KJ, Farrer MJ, Rocca WA, Pant PV, Frazer KA, Cox DR, Ballinger DG (2005) High-resolution whole-genome association study of Parkinson disease. Am J Hum Genet 77:685–693 (10.1086/496902) / Am J Hum Genet by DM Maraganore (2005)
  28. Marx FP, Holzmann C, Strauss KM, Li L, Eberhardt O, Gerhardt E, Cookson MR, Hernandez D, Farrer MJ, Kachergus J, Engelender S, Ross CA, Berger K, Schols L, Schulz JB, Riess O, Kruger R (2003) Identification and functional characterization of a novel R621C mutation in the synphilin-1 gene in Parkinson’s disease. Hum Mol Genet 12:1223–1231 (10.1093/hmg/ddg134) / Hum Mol Genet by FP Marx (2003)
  29. Morishima-Kawashima M, Hasegawa M, Takio K, Suzuki M, Yoshida H, Watanabe A, Titani K, Ihara Y (1995) Hyperphosphorylation of tau in PHF. Neurobiol Aging 16:365–371 (10.1016/0197-4580(95)00027-C) / Neurobiol Aging by M Morishima-Kawashima (1995)
  30. Myhre R, Klungland H, Farrer MJ, Aasly JO (2008) Genetic association study of synphilin-1 in idiopathic Parkinson’s disease. BMC Med Genet 9:19 (10.1186/1471-2350-9-19) / BMC Med Genet by R Myhre (2008)
  31. Nuber S, Franck T, Wolburg H, Schumann U, Casadei N, Fischer K, Calaminus C, Pichler BJ, Chanarat S, Teismann P, Schulz JB, Luft AR, Tomiuk J, Wilbertz J, Bornemann A, Kruger R, Riess O (2010) Transgenic overexpression of the alpha-synuclein interacting protein synphilin-1 leads to behavioral and neuropathological alterations in mice. Neurogenetics 11:107–120 (10.1007/s10048-009-0212-2) / Neurogenetics by S Nuber (2010)
  32. O’Farrell C, Murphy DD, Petrucelli L, Singleton AB, Hussey J, Farrer M, Hardy J, Dickson DW, Cookson MR (2001) Transfected synphilin-1 forms cytoplasmic inclusions in HEK293 cells. Brain Res Mol Brain Res 97:94–102 (10.1016/S0169-328X(01)00292-3) / Brain Res Mol Brain Res by C O’Farrell (2001)
  33. Onyango IG (2008) Mitochondrial dysfunction and oxidative stress in Parkinson’s disease. Neurochem Res 33:589–597 (10.1007/s11064-007-9482-y) / Neurochem Res by IG Onyango (2008)
  34. Rademakers R, Cruts M, Van Broeckhoven C (2004) The role of tau (MAPT) in frontotemporal dementia and related tauopathies. Hum Mutat 24:277–295 (10.1002/humu.20086) / Hum Mutat by R Rademakers (2004)
  35. Ribeiro CS, Carneiro K, Ross CA, Menezes JR, Engelender S (2002) Synphilin-1 is developmentally localized to synaptic terminals, and its association with synaptic vesicles is modulated by alpha-synuclein. J Biol Chem 277:23927–23933 (10.1074/jbc.M201115200) / J Biol Chem by CS Ribeiro (2002)
  36. Rossi S, Masotti D, Nardini C, Bonora E, Romeo G, Macii E, Benini L, Volinia S (2006) TOM: a web-based integrated approach for identification of candidate disease genes. Nucleic Acids Res 34:W285–W292 (10.1093/nar/gkl340) / Nucleic Acids Res by S Rossi (2006)
  37. Simon-Sanchez J, Schulte C, Bras JM, Sharma M, Gibbs JR, Berg D, Paisan-Ruiz C, Lichtner P, Scholz SW, Hernandez DG, Kruger R, Federoff M, Klein C, Goate A, Perlmutter J, Bonin M, Nalls MA, Illig T, Gieger C, Houlden H, Steffens M, Okun MS, Racette BA, Cookson MR, Foote KD, Fernandez HH, Traynor BJ, Schreiber S, Arepalli S, Zonozi R, Gwinn K, van der Brug M, Lopez G, Chanock SJ, Schatzkin A, Park Y, Hollenbeck A, Gao J, Huang X, Wood NW, Lorenz D, Deuschl G, Chen H, Riess O, Hardy JA, Singleton AB, Gasser T (2009) Genome-wide association study reveals genetic risk underlying Parkinson’s disease. Nat Genet 41:1308–1312 (10.1038/ng.487) / Nat Genet by J Simon-Sanchez (2009)
  38. Smith CL, Goldsmith CA, Eppig JT (2005) The mammalian phenotype ontology as a tool for annotating, analyzing and comparing phenotypic information. Genome Biol 6:R7 (10.1186/gb-2004-6-1-r7) / Genome Biol by CL Smith (2005)
  39. Takanashi M, Mori H, Arima K, Mizuno Y, Hattori N (2002) Expression patterns of tau mRNA isoforms correlate with susceptible lesions in progressive supranuclear palsy and corticobasal degeneration. Brain Res Mol Brain Res 104:210–219 (10.1016/S0169-328X(02)00382-0) / Brain Res Mol Brain Res by M Takanashi (2002)
  40. Thomas B, Beal MF (2007) Parkinson’s disease. Hum Mol Genet 16(Spec No. 2):R183–R194 (10.1093/hmg/ddm159) / Hum Mol Genet by B Thomas (2007)
  41. Tobin JE, Latourelle JC, Lew MF, Klein C, Suchowersky O, Shill HA, Golbe LI, Mark MH, Growdon JH, Wooten GF, Racette BA, Perlmutter JS, Watts R, Guttman M, Baker KB, Goldwurm S, Pezzoli G, Singer C, Saint-Hilaire MH, Hendricks AE, Williamson S, Nagle MW, Wilk JB, Massood T, Laramie JM, DeStefano AL, Litvan I, Nicholson G, Corbett A, Isaacson S, Burn DJ, Chinnery PF, Pramstaller PP, Sherman S, Al-hinti J, Drasby E, Nance M, Moller AT, Ostergaard K, Roxburgh R, Snow B, Slevin JT, Cambi F, Gusella JF, Myers RH (2008) Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study. Neurology 71:28–34 (10.1212/01.wnl.0000304051.01650.23) / Neurology by JE Tobin (2008)
  42. van Driel MA, Cuelenaere K, Kemmeren PP, Leunissen JA, Brunner HG (2003) A new web-based data mining tool for the identification of candidate genes for human genetic disorders. Eur J Hum Genet 11:57–63 (10.1038/sj.ejhg.5200918) / Eur J Hum Genet by MA Driel van (2003)
  43. Weingarten MD, Lockwood AH, Hwo SY, Kirschner MW (1975) A protein factor essential for microtubule assembly. Proc Natl Acad Sci USA 72:1858–1862 (10.1073/pnas.72.5.1858) / Proc Natl Acad Sci USA by MD Weingarten (1975)
  44. Wider C, Vilarino-Guell C, Jasinska-Myga B, Heckman MG, Soto-Ortolaza AI, Cobb SA, Aasly JO, Gibson JM, Lynch T, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA (2010) Association of the MAPT locus with Parkinson’s disease. Eur J Neurol 17:483–486 (10.1111/j.1468-1331.2009.02847.x) / Eur J Neurol by C Wider (2010)
  45. Wittwer CT, Reed GH, Gundry CN, Vandersteen JG, Pryor RJ (2003) High-resolution genotyping by amplicon melting analysis using LCGreen. Clin Chem 49:853–860 (10.1373/49.6.853) / Clin Chem by CT Wittwer (2003)
  46. Yu W, Wulf A, Liu T, Khoury MJ, Gwinn M (2008) Gene Prospector: an evidence gateway for evaluating potential susceptibility genes and interacting risk factors for human diseases. BMC Bioinformatics 9:528 (10.1186/1471-2105-9-528) / BMC Bioinformatics by W Yu (2008)
  47. Zabetian CP, Hutter CM, Factor SA, Nutt JG, Higgins DS, Griffith A, Roberts JW, Leis BC, Kay DM, Yearout D, Montimurro JS, Edwards KL, Samii A, Payami H (2007) Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson’s disease. Ann Neurol 62:137–144 (10.1002/ana.21157) / Ann Neurol by CP Zabetian (2007)
Dates
Type When
Created 14 years, 6 months ago (Feb. 22, 2011, 9:39 a.m.)
Deposited 6 years, 2 months ago (June 8, 2019, 3:06 p.m.)
Indexed 2 months ago (June 25, 2025, 3:12 a.m.)
Issued 14 years, 6 months ago (Feb. 23, 2011)
Published 14 years, 6 months ago (Feb. 23, 2011)
Published Online 14 years, 6 months ago (Feb. 23, 2011)
Published Print 14 years, 2 months ago (June 1, 2011)
Funders 0

None

@article{Keyser_2011, title={Identification of Parkinson’s disease candidate genes using CAESAR and screening of MAPT and SNCAIP in South African Parkinson’s disease patients}, volume={118}, ISSN={1435-1463}, url={http://dx.doi.org/10.1007/s00702-011-0591-z}, DOI={10.1007/s00702-011-0591-z}, number={6}, journal={Journal of Neural Transmission}, publisher={Springer Science and Business Media LLC}, author={Keyser, Rowena J. and Oppon, Ekow and Carr, Jonathan A. and Bardien, Soraya}, year={2011}, month=feb, pages={889–897} }